arrow
Y

Yong Chen

fudan university
H指数:18
被引数:1,328

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HLX07, a novel anti-EGFR antibody, for locally advanced and metastatic cutaneous squamous cell carcinoma: an open-label, multicenter, phase II trial

HLX07,一种新型抗EGFR抗体,用于局部晚期和转移性皮肤鳞状细胞癌:一项开放标签、多中心、II期临床试验

2026-08-040
PRE
Adjuvant short-course radiotherapy combined with chemotherapy and a PD-1 inhibitor for resected mucosal melanoma: study protocol for a single-arm, prospective, phase II trial

辅助短程放疗联合化疗和PD-1抑制剂治疗切除后黏膜黑色素瘤:单臂、前瞻性、II期试验研究方案

2026-04-160
PRE
Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study

基于机器学习的静脉血栓栓塞症风险预测早期预警系统的开发与验证:一项多中心回顾性队列研究

2025-08-130
OA
High-quality targeted temperature management combined with decompressive craniectomy in patients with poor-grade aneurysmal subarachnoid hemorrhage: a secondary analysis of a multicenter prospective study

高质量目标温度管理联合减压性颅骨切除术在低分级动脉瘤性蛛网膜下腔出血患者中的应用:一项多中心前瞻性研究的二次分析

2025-01-060
OA
Lenvatinib plus drug-eluting bead transarterial chemoembolization with or without hepatic arterial infusion chemotherapy for hepatocellular carcinoma (> 7 cm) with portal vein tumor thrombosis: A retrospective multicenter cohort study

仑伐替尼联合载药微球经动脉化疗栓塞(有或无肝动脉灌注化疗)治疗伴有门静脉癌栓的巨大(>7 cm)肝细胞癌:一项回顾性多中心队列研究

2024-09-010
PRE